In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Levoleucovorin Drug Master File in Korea (Levoleucovorin KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Levoleucovorin. The MFDS reviews the Levoleucovorin KDMF as part of the drug registration process and uses the information provided in the Levoleucovorin KDMF to evaluate the safety and efficacy of the drug.
After submitting a Levoleucovorin KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Levoleucovorin API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Levoleucovorin suppliers with KDMF on PharmaCompass.